Our commitment to quality is inherent in everything we do. Our high-quality products help to improve the health and everyday lives of people.
One of the main pillars of Prohealth is the Pharma Division. Since its inception in 1995, Prohealth has built a strong portfolio of European pharmaceutical companies offering branded, prescription, and OTC products that includes Ursapharm, Galderma, PIAM, Italchimici, Rowa, Laboratori Plants, Discovery, ICB, Natiris, and Azevedos.
Prohealth is entrusted with the registration, importation, marketing, and distribution of the products of its parent pharmaceutical companies in Malta. Such a process necessitates a high level of expertise in each field combined with excellent teamwork between the regulatory affairs, logistic, medical representatives, and pharmacy sales teams within this fast-growing division.
Success with such an extensive portfolio requires professional and ethical, yet consistent medical detailing of the highest level to a wide variety of medical specialists that include Ophthalmologists, Paediatricians, Family Doctors, Surgeons, Respiratory Physicians, ENT specialists, Psychiatrists, Geriatricians, Orthopaedic Surgeons, Gastroenterologists and Infectious Disease Physicians, to name a few. Interaction with pharmacists and other healthcare professionals, such as nurses and mid-wives is equally important to ensure optimal standards of care and consequential high patient satisfaction at all times. The Pharma Division’s experienced and qualified team of medical representatives is today very well-structured to meet the numerous challenges that lie ahead in this fast-changing marketplace.
In late 2009 Prohealth’s Pharma Division successfully launched Ursapharm products in Libya, and following the positive results obtained, it has recently been entrusted with the introduction of Ursapharm in other developing African markets.
Our company is at the forefront of innovation within the Maltese pharmaceutical market, with major brands such as Epiduo, Hysan, the HYLO® Range, Muciclar, and Clin Flor to name a few. HYLO®-COMOD was the first preservative-free eye lubricant in Malta to use a patented COMOD® system, and the recent addition of Galderma – the leader in dermatological pharmaceutical research worldwide – will further enhance this aspiration.
This wide variety of high quality products includes decongestant and soothing nasal sprays, a comprehensive range of anti-acne treatments, eye preparations for dryness, infections and allergies, oral antibiotics, cough syrups, probiotics, anti-asthmatics, ear antibiotics, and more.
Galderma has a significant history, starting in 1948, with a company called Spring Pharma in Olten, Switzerland. Later, in 1981, Nestle and L’Oreal formed Galderma as it is known today, which is the world’s number one dermatology company, focusing on acne, rosacea, psoriasis, and a number of other skin conditions.
For more than 30 years, Galderma has been dedicated to developing innovative medical dermatological solutions to help patients maintain healthy skin while improving their quality of life, and to help healthcare professionals worldwide. This while holding all products to the highest standard of safety and efficacy by partnering with dermatologists and other healthcare professionals in the field.
Prohealth is the exclusive distributor for Galderma Rx and A&C divisions in Malta, providing doctors and patients with products such as Epiduo, Soolantra, Etrivex, Differin, Loceryl, Rozex, and Tetralysal.
Chemist Azevedo, known today as Grupo Azevedos, was founded in 1775. The company is the first Portuguese developer and producer of medicines, and has always been at the forefront of development within the pharmaceutical field.
Grupo Azevedos produced the first penicillin ointment, developed the very first antibiotic against the Typhus Fever, as well as the first Poliomyelitis vaccine in Portugal.
This is a company that strives towards loyalty and innovation, helping to set new standards in the pharmaceutical industry. Grupo Azevedos values assertiveness, honesty, respect, partnership, and professionalism.
A family owned company based in Jaworzno, Poland, ICB Pharma is a leader when it comes to both quality and efficacy in the healthcare and sanitary hygiene fields.
Using its own research and development laboratory, ICB Pharma strives to continuously develop better formulation enhancements within the area of “quasi-pharma”, and sanitary hygiene products. These are based on a unique solid core micro and nano encapsulation technology.
ICB Pharma export their products to countries all around the world, with Prohealth in charge of distributing Nitolic to the Maltese market. Nitolic is a specific formula that targets and completely eliminates head lice.
Italchimici is an Italian company founded in the 1960s by the Guastella family. Throughout the years, the company has been through a number of changes, the latest being in July of 2015, when Progressio SGR and Idea Capital Funds – two private equity funds – acquired it.
Due to its innovative therapeutic solutions, and the high level of quality and safety that it adheres to, Italchimici holds both an excellent reputation, and strong credibility within the healthcare market, particularly in the areas of gastro and respiratory drugs.
Italchimici develops a wide array of products, of which Aircort Nasal Spray, Aircort Inhaler, Cexidal, and Krovaneg are distributed by Prohealth.
An Italian company based in Giammoro (ME), Italy, Laboratori PLANTS was founded in 1989. The company specialises in the manufacture of different forms of liquid and solid oral food supplements, including probiotics.
Laboratori PLANTS is dedicated to developing new and improved techniques in the field of pharmaceutical food supplements, applying knowledge gained through extensive research and innovation while using the latest technologies. The best quality is ensured thanks to constant physical-chemical, and microbiological analyses on all products – this includes compatibility testing with packaging materials.
Laboratori PLANTS entrusted Prohealth to distribute Clinflor in Malta, a unique blend of probiotics which include Saccharomyces and Lactobacilli. Clinflor helps replenish and balance natural bacteria in the gut.
Rowa is a company on a mission to remain one of the leading contenders in the pharmaceutical field, and to strengthen its global presence. It strives for these goals by adhering to a strict quality assurance policy, with laboratories that meet the highest in technological standards. Rowa products are currently available in over 70 countries.
Rowa is also the parent company of Rowex Ltd, which is the company’s Irish Marketing division, established in 1993. Rowex is a forward-thinking, innovative company that aims to continue developing and manufacturing high-quality but affordable medicines which are available to everyone.
Rowex owes its worldwide success to the fact that each product satisfies strict standards.
Natiris, founded in 1971, is a nutritional supplement innovator and manufacturer based in Sintra, Portugal. The company prides itself on its dedication to providing products of high quality, efficacy and safety, which is based on its team’s rigorous research.
Due to its tendency to anticipate trends, as well as responding proactively to the various needs of the market, in the past 45 years, Natiris has established itself as a leader that is constantly developing its skills while generating competitive advantages within the field of nutritional supplements.
Natiris products are exported to a number of countries, including Malta. Prohealth has been entrusted with the distribution of supplements such as the CEREBRUM range, and JOINTFLEX to Maltese pharmacies.
Founded in 1915 in Genoa, Italy, PIAM is one of the contemporary leaders in the field of common and rare illnesses. The company’s dedication towards the incorporation of ethical measures in its research and production process is imperative in making PIAM a company well known for quality.
PIAM combines excellence with the guarantee for patient satisfaction, as well as passion and innovation, ensuring that patients are well taken care of and safe.
One of their better known products is Muciclar. Taken either as Capsules or in syrup form, Muciclar is used to aid with acute and chronic bronchopulmonary diseases, usually connected to abnormal mucus secretion as well as impaired mucus transport.
Ursapharm is a German company turned global, founded in 1974. For over 30 years now, the company has striven to turn innovative pharmaceutical concepts into successful medicinal products and medical devices. Thanks to its vast portfolio, today, Ursapharm is one of the market leaders in the field of ophthalmology in Germany, and in the area of dry eye syndrome in Europe.
Adhering to national and international quality standards is paramount during product development, which is why Ursapharm maintains very strict criteria for all their products, which include Hysan nasal sprays, Hylo eye lubricants, and Azelastin-POS Eye Drops to treat acute, and chronic allergic conjunctivitis.
Its patented COMOD™ delivery system allows Ursapharm to provide preservative-free eye drops and nasal sprays which remain sterile for up to 6 months after first opening, making these products safer and more cost effective to our patients.
Thanks to a dedicated group of staff, as well as continuous investment and research to remain up-to-date when it comes to production facilities and the implementation of environmentally compliant techniques, Ursapharm continues to be a reliable partner within the healthcare and contract manufacture fields.